Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05849441
Other study ID # MindfulnessinTeens-SBIR-23-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 18, 2023
Est. completion date September 2024

Study information

Verified date June 2024
Source Innovation Research & Training
Contact Alison Parker, PhD
Phone 919-493-7700
Email aparker@irtinc.us
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to evaluate the effectiveness of the Aware Program, an online mindfulness education program, with adolescents with 22q11DS and their parents.


Description:

Parent-adolescent pairs (N=60) will be recruited to participate in a randomized controlled trial. Consent, permission, and/or assent will be sought prior to participation in the study. Participant pairs will be randomized into one of two study arms: intervention and wait-list control. All participants will complete a web-based pre-test questionnaire. Adolescents and parents in the intervention group will then receive access to the Aware Program for four weeks. Approximately 4-5 weeks after completing the pre-test questionnaire, all participants will complete a web-based post-test questionnaire (the post-test for the intervention group will include Consumer Satisfaction questions about the program). Adolescents and parents in the wait-list control group will then have the option of reviewing the Aware Program and will receive access for four weeks. After approximately four weeks, they will have the opportunity to complete the Consumer Satisfaction Questionnaire about the program.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date September 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 19 Years
Eligibility Inclusion Criteria: To be included in the study, youth must: - Have received a diagnosis of 22Q11.DS (also known as VeloCardioFacial Syndrome or DiGeorge syndrome) - Be between the ages of 12 and 19 years old - Have an IQ of greater than or equal to 55 - Have regular internet and computer access - Speak and read English (all study and program materials are in English) To be included in the study, parents must: - Have a participating youth in the study - Read fluently in English (all study and program materials are in English) Exclusion Criteria: - Only one parent per youth may participate

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Aware Program
The program includes interactive, multimedia lessons for adolescent participants to learn, practice, and apply different mindfulness skills. Parent-adolescent pairs will have the option to subscribe to a mobile messaging service that includes progress reminders, encouragement, and practice content. Parent participants also have access to online resources to support and monitor their teen's use of the program.

Locations

Country Name City State
United States innovation Research & Training Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Innovation Research & Training

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in adolescents' coping skills Adolescents will be asked to respond to 34 questions (e.g., Try to think of different ways to solve it; 1 = Never; 5 = Always) that assess their coping in response to stressors across 5 domains: Seeking Social Support, Problem Solving, Distancing, Externalizing, and Internalizing. Three items related to mindfulness skills will be included as a mindfulness subscale. Responses will be averaged across each domain and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater use of the coping strategy. Baseline and Week 4
Primary Change from baseline in adolescents' emotion regulation Adolescents will be asked to respond to 10 questions (e.g., I keep my emotions to myself; 1 = Strongly disagree; 7 = Strongly agree) that assess their use of two emotion regulation strategies: Cognitive Reappraisal and Suppression. Responses will be averaged across each strategy and the minimum scale is 1 and the maximum scale score is 7. Higher scores indicate greater use of the emotion regulation strategy. Baseline and Week 4
Primary Change from baseline in adolescents' emotional self-efficacy Adolescents will be asked to respond to 27 questions (e.g., I can tell when my feelings change; 1 = Not confident at all; 5 = Very confident) that assess their beliefs about their ability to understand and manage emotions. The measure has four factors: Using and managing your own emotions; Identifying and understanding your own emotions; Dealing with emotions in others; Perceiving emotion through facial expressions and body language. Responses will be averaged across the four factors and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater emotional self-efficacy. Baseline and Week 4
Primary Change from baseline in adolescents' general anxiety Adolescents will be asked to respond to 7 items that assess general anxiety (e.g., Over the last two weeks, how often have you been bothered by the following problems… feeling nervous, anxious, or on edge; 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day). Responses will be averaged and the minimum scale score is 0 and the maximum scale score is 3. Higher scores indicate greater general anxiety. Baseline and Week 4
Primary Change from baseline in adolescents' social anxiety Adolescents will be asked to respond to 18 items (e.g., It's hard for me to ask others to do things with me; 1 = Not at all; 5 = All the time) that assess social anxiety. The measure has three factors: Fear of Negative Evaluation, Social Avoidance and Distress-New; Social Avoidance and Distress. Responses will be averaged across the three factors and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater social anxiety. Baseline and Week 4
Primary Change from baseline in adolescents' wellbeing Adolescents will be asked to respond to a total of 7 items that assess their overall health and wellbeing. Adolescents will respond to 4 items (e.g., In general, would you say your quality of life is…; 5 = Excellent, 1 = Poor); 1 item (e.g., How often do you feel really sad; 5 = Never; 1 = Always); and 2 items (e.g., How often do you have fun with friends?; 5 = Always; 1 = Never). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater wellbeing. Baseline and Week 4
Primary Change from baseline in parent report of adolescents' emotion regulation Parents will be asked to respond to 24 questions (e.g., Responds positively to neutral or friendly overtures by peers; 1= Never; 4 = Always) that assess parent ratings of their adolescents' emotion regulatory abilities. There are two subscales for this measure: Emotion Regulation and Negativity. Responses will be averaged across the two subscales and the minimum scale score is 1 and the maximum scale score is 4. Higher scores indicate greater use of the emotion regulation strategy. Baseline and Week 4
Primary Change from baseline in parent report of adolescents' executive functioning Parents will be asked to respond to 24 questions (e.g., Has difficulty thinking ahead or learning from experience; 1 = Definitely not true; 5 = Definitely true) that assess parent ratings of their adolescents' executive functioning. There are four subscales: Working Memory, Planning, Inhibition, and Regulation. Responses will be averaged across the four subscales and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater executive functioning. Baseline and Week 4
Primary Change from baseline in parent report of adolescents' anxiety Parents will be asked to respond to 8 questions (e.g., My child worries about things; 1 = Never; 4 = Always) that assess parent ratings of their adolescents' anxiety. Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 4. Higher scores indicate greater anxiety. Baseline and Week 4
Primary Change from baseline in parent report of adolescents' wellbeing Parents will be asked to respond to a total of 7 items that assess parent ratings of their adolescents' overall health and wellbeing. Parents will respond to 4 items (e.g., In general, would you say your child's quality of life is…; 5 = Excellent, 1 = Poor); 1 item (e.g., How often does your child feel really sad; 5 = Never; 1 = Always); and 2 items (e.g., How often does your child have fun with friends?; 5 = Always; 1 = Never). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater wellbeing. Baseline and Week 4
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT05664412 - Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome N/A
Recruiting NCT04463316 - GROWing Up With Rare GENEtic Syndromes
Not yet recruiting NCT02070211 - Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. Phase 2/Phase 3
Completed NCT05290493 - NB-001 in Children and Adolescents With 22q11 Deletion Syndrome Phase 2
Completed NCT02381457 - SNP-based Microdeletion and Aneuploidy RegisTry (SMART)